Stereotaxis Inc (STXS) gains 1.08% for July 21

Equities Staff  |

Stereotaxis Inc (NYSE: STXS) shares gained 1.08%, or $0.1 per share, to close Wednesday at $9.35. After opening the day at $9.15, shares of Stereotaxis fluctuated between $9.36 and $9.15. 220,331 shares traded hands a decrease from their 30 day average of 391,859. Wednesday's activity brought Stereotaxis’s market cap to $692,965,610.

Stereotaxis is headquartered in St Louis, Missouri..

About Stereotaxis Inc

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The core components of Stereotaxis' systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere.

Visit Stereotaxis Inc’s profile for more information.

About The New York Stock Exchange

The New York Stock Exchange is the world’s largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Stereotaxis Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Stereotaxis Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content